https://www.cytoimmunebiologics.com/press-release/car-nk-cell-therapy-directed-against-pancreatic-cancer/2022-02-03T11:21:24+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-announces-appointment-of-industry-veteran-douglas-e-williams-ph-d-to-board-of-directors/2022-02-03T11:22:24+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-welcomes-aleksey-krylov-chief-financial-officer/2022-02-03T11:23:03+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-not-affected-by-the-recent-challenges-in-allogeneic-car-t-cell-engineering/2022-02-03T11:23:30+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-appoints-renowned-oncologist-and-immunologist-as-new-chief-executive-officer/2022-02-03T11:23:56+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-announces-publication-demonstrating-platelet-derived-growth-factor-d-signaling-activates-natural-killer-nk-cells-and-enhances-nk-cell-survival/2022-02-15T12:55:46+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-appoints-distinguished-cell-therapy-and-chemistry-manufacturing-and-controls-expert-as-puerto-rico-based-chief-operating-officer/2022-02-15T13:20:00+00:00https://www.cytoimmunebiologics.com/press-release/city-of-hope-and-cytoimmune-announce-study-demonstrating-novel-off-the-shelf-chimeric-antigen-receptor-car-natural-killer-nk-cell-based-therapy-against-pancreatic-cancer/2022-02-15T13:43:23+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-to-present-new-preclinical-data-highlighting-potential-of-novel-track-nk-cell-therapies-as-treatments-for-both-solid-tumors-and-hematologic-malignancies/2023-07-26T13:12:37+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-inc-opens-the-companys-clinical-cell-manufacturing-facility-in-toa-baja/2022-03-24T18:35:47+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-ushers-in-new-era-with-appointment-of-dr-jose-eduardo-vidal-as-ceo-to-spearhead-focus-on-cell-therapy-development/2023-07-27T11:06:47+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-to-participate-in-upcoming-april-investor-conferences/2023-07-26T13:12:29+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-presents-new-preclinical-data-demonstrating-potential-of-its-novel-off-the-shelf-natural-killer-cell-based-therapies-for-the-treatment-of-hematologic-and-solid-tumor-cancers-at-aacr/2023-07-26T13:11:28+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-and-city-of-hope-announce-first-patient-dosed-in-a-phase-1-trial-evaluating-a-novel-off-the-shelf-engineered-natural-killer-cellular-therapy-for-the-treatment-of-non-small-cell/2023-07-26T13:11:44+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-appoints-remus-vezan-m-d-ph-d-as-chief-medical-officer/2023-07-26T13:11:59+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-to-present-preclinical-data-highlighting-potential-of-novel-track-nk-cells-to-selectively-target-and-kill-hematologic-and-solid-tumor-cancer-cells/2023-07-26T13:12:18+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-appoints-yulii-bogatyrenko-as-chief-business-officer-and-expands-the-board-of-directors-with-the-appointment-of-graeme-bell/2023-07-26T13:12:10+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-broadens-services-a-new-chapter-in-development-and-manufacturing-of-cell-therapies/2023-07-27T11:07:03+00:00https://www.cytoimmunebiologics.com/press-release/cytoimmune-therapeutics-expands-phase-1-trial-of-cyto-102/2023-12-15T13:17:21+00:00